Alternatives to Nuritas

Nuritas is a Biotechnology tool: discovering and developing novel, high-value ingredients for food and health. Here are the 53 closest alternatives, compared on pricing, features and what real users say.

Nuritas profile More Biotechnology alternatives

The 20 closest Biotechnology companies to Nuritas

NanoStruct
Not rated
Develops nanostructured sensor chips for rapid pathogen identification in food.
Visit site
Apoha
Not rated
Pioneering Liquid State Intelligence for physical-world AI.
Visit site
PL
Planetary
Not rated
Building the industrial backbone of the bioeconomy through full-stack fermentation.
Fermeate
Not rated
Industrial biotechnology company developing optogenetic control for industrial-scale precision fermentation.
Visit site
Moderna
2.0 out of 5 (1)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site
BioNTech
Not rated
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Visit site
JU
Juno Therapeutics
Not rated
Biotechnology company focused on developing cancer immunotherapies.
Kite Pharma
Not rated
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Visit site
CRISPR Therapeutics
Not rated
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Visit site
Mammoth Biosciences
Not rated
Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Visit site
Epicrispr Biotechnologies
Not rated
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Visit site
Pixelgen Technologies
Not rated
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Visit site
Seaport Therapeutics
Not rated
Developing novel therapeutics to restore gut lymphatic function.
Visit site
Degron Therapeutics
Not rated
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Visit site
Vizgen
Not rated
Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
Visit site
CellCentric
Not rated
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Visit site
Quartzy
Not rated
A vertically-integrated procurement platform for the life sciences industry.
Visit site
Adcendo
Not rated
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Visit site
Supernus Pharmaceuticals
Not rated
Biopharmaceutical company developing and commercializing CNS disease treatments.
Visit site
LifeMine Therapeutics Inc.
Not rated
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Visit site

Company	Rating	Visit
NanoStructDevelops nanostructured sensor chips for rapid pathogen identification in food.	Not rated	Visit site
ApohaPioneering Liquid State Intelligence for physical-world AI.	Not rated	Visit site
PLPlanetaryBuilding the industrial backbone of the bioeconomy through full-stack fermentation.	Not rated
FermeateIndustrial biotechnology company developing optogenetic control for industrial-scale precision fermentation.	Not rated	Visit site
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.0 out of 5 (1)	Visit site
BioNTechGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.	Not rated	Visit site
JUJuno TherapeuticsBiotechnology company focused on developing cancer immunotherapies.	Not rated
Kite PharmaBiotechnology company developing and commercializing cell therapies for cancer treatment.	Not rated	Visit site
CRISPR TherapeuticsBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.	Not rated	Visit site
Mammoth BiosciencesBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.	Not rated	Visit site
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).	Not rated	Visit site
Pixelgen TechnologiesA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.	Not rated	Visit site
Seaport TherapeuticsDeveloping novel therapeutics to restore gut lymphatic function.	Not rated	Visit site
Degron TherapeuticsClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.	Not rated	Visit site
VizgenSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.	Not rated	Visit site
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.	Not rated	Visit site
QuartzyA vertically-integrated procurement platform for the life sciences industry.	Not rated	Visit site
AdcendoDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.	Not rated	Visit site
Supernus PharmaceuticalsBiopharmaceutical company developing and commercializing CNS disease treatments.	Not rated	Visit site
LifeMine Therapeutics Inc.Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Nuritas profile.

Sponsored rows are paid and labelled. Advertise on this page